Genor Biopharma targets $371m from Hong Kong IPO
JHBP (CY) Holdings, a holding company for China’s Genor Biopharma, hit the road for its Hong Kong IPO on Wednesday. It is aiming to raise up to HK$2.9bn ($371.2m).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: